Raj Denhoy
Stock Analyst at Jefferies
(3.04)
# 1,401
Out of 4,761 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $134.92 | -11.06% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $73.30 | +77.35% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $64.49 | +70.57% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $7.48 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $88.78 | -64.80% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $18.00 | +94.44% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $175.64 | +67.96% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $47.44 | +91.82% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $78.23 | -65.49% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $282.80 | -76.31% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $134.92
Upside: -11.06%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $73.30
Upside: +77.35%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $64.49
Upside: +70.57%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $7.48
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $88.78
Upside: -64.80%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $18.00
Upside: +94.44%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $175.64
Upside: +67.96%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $47.44
Upside: +91.82%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $78.23
Upside: -65.49%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $282.80
Upside: -76.31%